Innocan Pharma (INNPF) Net Income towards Common Stockholders (2024 - 2025)
Innocan Pharma's Net Income towards Common Stockholders was $2.78 million in the quarter ended Dec 31, 2025, up 40.2% from $1.98 million a year earlier.
Powered by 
Analysis
Innocan Pharma (INNPF) Net Income towards Common Stockholders (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Net Income towards Common Stockholders at Innocan Pharma came in at -$341,000.
- In earlier years, Net Income towards Common Stockholders was $262,000 in the year ended Dec 31, 2024 (-93.8%) and $4.25 million in the year ended Dec 31, 2023.
- The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Net Income towards Common Stockholders in data going back to the quarter ended Mar 31, 2024.
- Per Business Quant data, INNPF's Net Income towards Common Stockholders in the three quarters before the quarter ended Dec 31, 2025 was -$1.95 million (quarter ended Sep 30, 2025), -$590,000 (quarter ended Jun 30, 2025) and -$229,000 (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 2.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -590,000.00 |
| Mar 31, 2025 | -229,000.00 |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | -290,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Mar 31, 2024 | -1.45 Mn |
API Access
Innocan Pharma Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();